What are the causes of inflammatory atelectasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Inflammatory Atelectasis

Inflammatory atelectasis is primarily caused by inflammatory processes that lead to airway obstruction, increased surface tension in alveoli, and compression of lung parenchyma due to inflammatory exudates.

Primary Inflammatory Causes

Systemic Autoimmune Diseases

  • Connective Tissue Disorders
    • Systemic Lupus Erythematosus (SLE) - can cause plate-like atelectasis 1
    • Rheumatoid Arthritis - associated with bronchiolitis and interstitial lung disease leading to atelectasis 1
    • Sjögren's Syndrome - causes xerotrachea (dryness of the trachea) leading to discoid atelectasis 1
    • Scleroderma - can cause interstitial lung disease with subsequent atelectasis 1

Inflammatory Airway Processes

  • Infectious Causes
    • Mycoplasma pneumoniae - can cause bronchial wall inflammation and edema leading to obstruction and atelectasis 2
    • Bacterial pneumonia - inflammatory exudates can obstruct airways
    • Viral respiratory infections - cause mucosal inflammation and increased secretions

Post-Injury Inflammatory Syndromes

  • Post-Cardiac Injury Syndromes (PCIS)
    • Post-pericardiotomy syndrome
    • Post-traumatic pericarditis
    • These have immune-mediated pathogenesis triggered by damage to pericardial/pleural tissues 1

Pathophysiological Mechanisms

Inflammatory Mediator-Driven Mechanisms

  • Cytokine-Mediated Inflammation

    • Proinflammatory cytokines (TNF-α, IL-1, IL-6, IL-8) increase during inflammatory processes 1
    • These cytokines promote neutrophil chemotaxis and activation
    • Lack of anti-inflammatory cytokines (IL-10) contributes to persistent inflammation 1
  • Cellular Mechanisms

    • Neutrophil infiltration and enzyme release
    • Macrophage activation and inflammatory mediator production
    • Reactive oxygen species generation and lipid peroxidation 1

Specific Mechanisms Leading to Atelectasis

  1. Airway Obstruction (Resorption Atelectasis)

    • Inflammatory edema of bronchial walls
    • Excessive mucus production and plugging
    • Bronchospasm secondary to inflammation
    • Cellular debris accumulation in airways 3
  2. Surfactant Dysfunction (Adhesive Atelectasis)

    • Inflammatory mediators inactivate surfactant
    • Decreased surfactant production by damaged type II pneumocytes
    • Increased surface tension causing alveolar collapse 3
  3. Compressive Mechanisms

    • Pleural effusions secondary to inflammation
    • Inflammatory exudates in interstitial spaces
    • Fibrotic changes in chronic inflammation 4

Clinical Presentations of Inflammatory Atelectasis

  • Acute Inflammatory Atelectasis

    • Sudden onset with respiratory distress
    • Often associated with acute infections or inflammatory conditions
    • May present with fever, cough, and pleuritic chest pain
  • Chronic Inflammatory Atelectasis

    • Gradual onset with progressive dyspnea
    • Associated with chronic inflammatory conditions
    • May present with recurrent infections and progressive respiratory insufficiency

Radiographic Patterns

  • Direct Signs of Atelectasis

    • Crowded pulmonary vessels
    • Crowded air bronchograms
    • Displacement of interlobar fissures 4
  • Indirect Signs

    • Pulmonary opacification
    • Elevation of the diaphragm
    • Shift of mediastinal structures
    • Compensatory hyperexpansion of surrounding lung 4

Diagnostic Approach

  • Imaging Studies

    • Chest radiography (AP and lateral views) to document presence of atelectasis 3
    • Chest CT with IV contrast for suspected tracheal or bronchial stenosis 5
    • HRCT to identify the "comet sign" in rounded atelectasis 5
  • Laboratory Evaluation

    • Inflammatory markers (CRP, ESR)
    • Autoimmune serologies when systemic autoimmune disease is suspected
    • Microbiological studies when infection is suspected

Management Considerations

  • Treatment of Underlying Inflammation

    • Target the specific inflammatory process causing atelectasis
    • For autoimmune diseases: immunosuppressive therapy directed at controlling the underlying disease 1
    • For infectious causes: appropriate antimicrobial therapy
  • Atelectasis-Specific Management

    • Positioning with head of bed elevated 30 degrees
    • Early mobilization and deep breathing exercises
    • Incentive spirometry to improve ventilation 5
    • Airway clearance techniques 1-2 times daily 5
    • Bronchoscopy for persistent mucous plugs 3
  • Advanced Respiratory Support

    • PEEP (10-15 cm H₂O) for intubated patients
    • CPAP or non-invasive positive pressure ventilation
    • Alveolar recruitment maneuvers 5

Monitoring and Complications

  • Monitoring

    • Arterial blood gases to assess oxygenation
    • Follow-up chest radiographs to document resolution 5
  • Potential Complications

    • Secondary bacterial pneumonia
    • Hypercapnic respiratory failure
    • Progression to chronic inflammatory lung disease 5

Understanding the specific inflammatory mechanism causing atelectasis is crucial for appropriate management and prevention of long-term complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Atelectasis caused by macrolide-resistant Mycoplasma pneumoniae pneumonia in an adult patient.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013

Research

Atelectasis: mechanisms, diagnosis and management.

Paediatric respiratory reviews, 2000

Research

Types and mechanisms of pulmonary atelectasis.

Journal of thoracic imaging, 1996

Guideline

Atelectasis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.